PolyPid to Participate in Three Upcoming Fall Investor Conference

PETACH TIKVA, Israel, Sept. 03, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company’s management will participate in the following three investor conferences: H.C.